Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4846876, 9 pages
https://doi.org/10.1155/2017/4846876
Research Article

Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway

1Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China
2Gastroenterology Department, Dongfang Hospital, Beijing University of Chinese Medicine, No. 6, 1st Section, Fangxingyuan, Fangzhuang, Beijing 100078, China
3China-Japan Friendship Hospital, No. 2, Cherry East Road, Beijing 100029, China
4Gastroenterology Department, The First Affiliated Hospital, Shanxi University of Chinese Medicine, No. 2, Weiyang West Road, Xianyang 712000, China
5Gastroenterology Department, The First Affiliated Hospital, Anhui University of Chinese Medicine, No. 117, Mei Shan Road, Hefei 230031, China

Correspondence should be addressed to Rui Shi; moc.361@885iaihs

Received 5 February 2017; Accepted 21 August 2017; Published 12 October 2017

Academic Editor: Steve Harakeh

Copyright © 2017 Tangyou Mao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Liu, T. Liu, X. Wang, X. Zheng, H. Wang, and L. Ma, “Effects of Guchang Capsule on Dextran Sulphate Sodium-Induced Experimental Ulcerative Colitis in Mice,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 3150651, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Xu, C. Xu, S. M. Saud et al., “Effect of Kuijie Granule on the Expression of TGF- β /Smads Signaling Pathway in Patients with Ulcerative Colitis,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 2601830, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Sartor, “Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis,” Nature Clinical Practice Gastroenterology and Hepatology, vol. 3, no. 7, pp. 390–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Xavier and D. K. Podolsky, “Unravelling the pathogenesis of inflammatory bowel disease,” Nature, vol. 448, no. 7152, pp. 427–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Sclano, “Asthma, nasal polyposis and ulcerative colitis: A new perspective,” Clinical and Experimental Allergy, vol. 32, no. 8, pp. 1144–1149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. APDW 2004 Chinese IBD Working Group, “Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003,” Journal of Gastroenterology and Hepatology, vol. 21, no. 6, pp. 1009–1015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Munkholm, “Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 18, no. s2, pp. 1–5, 2003. View at Publisher · View at Google Scholar
  8. J. A. Eaden, K. R. Abrams, and J. F. Mayberry, “The risk of colorectal cancer in ulcerative colitis: a meta-analysis,” Gut, vol. 48, no. 4, pp. 526–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. G. Ording, E. Horváth-Puhó, R. Erichsen et al., “Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.,” Inflammatory bowel diseases, vol. 19, no. 4, pp. 800–805, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Matsuoka, H. Ikeuchi, M. Uchino et al., “Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort,” International Journal of Colorectal Disease, vol. 28, no. 6, pp. 829–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ullman, R. Odze, and F. A. Farraye, “Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon,” Inflammatory Bowel Diseases, vol. 15, no. 4, pp. 630–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Kauder, L. Santell, E. Mai et al., “Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele,” PLoS ONE, vol. 8, no. 12, Article ID e83958, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. M. Kulkarni, W. D. Stuart, D. Gurusamy, and S. E. Waltz, “Ron receptor signaling is protective against DSS-induced colitis in mice,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 306, no. 12, pp. G1065–G1074, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Witte, L. F. A. Huitema, E. E. S. Nieuwenhuis, and S. Brugman, “Deficiency in macrophage-stimulating protein results in spontaneous intestinal inflammation and increased susceptibility toward epithelial damage in zebrafish,” The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 11, no. 6, pp. 542–550, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Bhatt, A. Welm, C. J. Farady, M. Vásquez, K. Wilson, and C. S. Craik, “Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 14, pp. 5771–5776, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. K. Wagh, B. E. Peace, and S. E. Waltz, “Met-Related Receptor Tyrosine Kinase Ron in Tumor Growth and Metastasis,” Advances in Cancer Research, vol. 100, pp. 1–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Gorlatova, K. Chao, L. R. Pal et al., “Protein characterization of a candidate mechanism SNP for Crohn's disease: The macrophage stimulating protein R689C substitution,” PLoS ONE, vol. 6, no. 11, Article ID e27269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Daperno, R. Sostegni, R. Rocca et al., “Medical treatment of severe ulcerative colitis,” Alimentary Pharmacology and Therapeutics, vol. 16, supplement 4, pp. 7–12, 2002. View at Publisher · View at Google Scholar
  19. J. Torres, R. K. Boyapati, N. A. Kennedy, E. Louis, J.-F. Colombel, and J. Satsangi, “Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease,” Gastroenterology, vol. 149, no. 7, pp. 1716–1730, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Chen, Clinical effect of qingchang wenzhong on the treatment of ulcerative colitis, Beijing University of Chinese Medicine, Beijing, China, 2015.
  21. L. J. Liu, Y. L. Wang, R. Shi et al., “Effect of Qingchang Wenzhong Decoction on colonic mucosa of TNBS-induced colitis rats,” Global Traditional Chinese Medicine, vol. 7, no. 3, pp. 187–191, 2014 (Chinese). View at Google Scholar
  22. T.-Y. Mao, R. Shi, W.-H. Zhao et al., “Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 4312538, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. W. D. Stuart, R. M. Kulkarni, J. K. Gray, J. Vasiliauskas, M. A. Leonis, and S. E. Waltz, “Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice,” Hepatology, vol. 53, no. 5, pp. 1618–1628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR.,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Jing, A. Rajput, J. L. C. Kan et al., “Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma,” Journal of Biological Chemistry, vol. 284, no. 16, pp. 10912–10922, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Randall, N. Henderson, J. Reens et al., “Claudin-2 expression levels in ulcerative colitis: Development and validation of an in-situ hybridisation assay for therapeutic studies,” PLoS ONE, vol. 11, no. 9, Article ID e0162076, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Kaser, S. Zeissig, and R. S. Blumberg, “Inflammatory bowel disease,” Annual Review of Immunology, vol. 28, pp. 573–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. R. Targan and L. C. Karp, “Defects in mucosal immunity leading to ulcerative colitis,” Immunological Reviews, vol. 206, pp. 296–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. B. Sartor, “Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases,” The American Journal of Gastroenterology, vol. 92, no. 12, pp. 5–11, 1997. View at Google Scholar
  30. F. Casellas I Jordà, “TNF inhibitors in inflamatory bowel disease,” Medicina Clinica, vol. 123, no. 16, pp. 627–634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Chaudhuri, “Regulation of macrophage polarization by RON receptor tyrosine kinase signaling,” Frontiers in Immunology, vol. 5, article 546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M.-H. Wang, Y.-Q. Zhou, and Y.-Q. Chen, “Macrophage-stimulating protein and RON receptor tyrosine kinase: Potential regulators of macrophage inflammatory activities,” Scandinavian Journal of Immunology, vol. 56, no. 6, pp. 545–553, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. Selvaraj, R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra, “Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor,” Blood, vol. 102, no. 4, pp. 1515–1524, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. L. Sabater, E. J. Andreu, M. García-Guzmán et al., “Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation,” Investigative Ophthalmology and Visual Science, vol. 58, no. 2, pp. 745–754, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. R. F. Shan, Y. F. Zhou, A. F. Peng, and Z. G. Jie, “Inhibition of aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro,” Experimental and Therapeutic Medicine, vol. 8, no. 3, pp. 1005–1009, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. X. L. Huang, J. Xu, X. H. Zhang et al., “PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis,” Inflammation Research, vol. 60, no. 8, pp. 727–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Stio, L. Retico, V. Annese, and A. G. Bonanomi, “Vitamin D regulates the tight-junction protein expression in active ulcerative colitis,” Scandinavian Journal of Gastroenterology, vol. 51, no. 10, pp. 1193–1199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. L.-C. Tong, Y. Wang, Z.-B. Wang et al., “Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress,” Frontiers in Pharmacology, vol. 7, article 253, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Das, P. Goswami, T. K. Das et al., “Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective,” Virchows Archiv, vol. 460, no. 3, pp. 261–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Zhang, H.-P. Yao, and M.-H. Wang, “Activation of RON differentially regulates claudin expression and localization: Role of claudin-1 in RON-mediated epithelial cell motility,” Carcinogenesis, vol. 29, no. 3, pp. 552–559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. N. J. Ronaghan, J. Shang, V. Iablokov et al., “The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 311, no. 3, pp. G466–G479, 2016. View at Publisher · View at Google Scholar
  42. Y. Jiang, L. Liu, and J. J. Steinle, “Compound 49b regulates ZO-1 and occludin levels in human retinal endothelial cells and in mouse retinal vasculature,” Investigative Opthalmology ~~~~~~~~~^~^~^~^~~~~~~~~~~~amp; Visual Science, vol. 58, no. 1, pp. 185–189, 2017. View at Publisher · View at Google Scholar